Managed to get my allocation on application. Very happy with the outcome.
Looking forward to seeing how the Noxopharm plan progresses. Key points for me are:
> NOX66 is a novel formulation of an effective compound - idronoxil
> Broad application across a range of cancers
> Trials in Eastern Europe is lower cost, the process quicker and apparently the ‘quality’ of patients is better since this may be their first treatment instead of last
> GK experienced at Human Trials and bringing drugs to market
All thumbs up for me plus a low enterprise value mean a strong investment opportunity I think. Let’s see if we start getting some good news in 2016 to set us up for a strong 2017
GLTA
- Forums
- ASX - By Stock
- Listing today
Managed to get my allocation on application. Very happy with the...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
8.7¢ |
Change
-0.006(6.45%) |
Mkt cap ! $25.42M |
Open | High | Low | Value | Volume |
9.2¢ | 9.2¢ | 8.3¢ | $44.27K | 511.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 8.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.0¢ | 22476 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 17000 | 0.087 |
1 | 21340 | 0.086 |
2 | 15601 | 0.085 |
4 | 134754 | 0.083 |
2 | 115000 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.090 | 22476 | 2 |
0.095 | 4200 | 1 |
0.096 | 35000 | 1 |
0.099 | 30800 | 2 |
0.100 | 312884 | 2 |
Last trade - 15.41pm 15/08/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online